IDEAYA Biosciences, Inc. (IDYA)
40.11
-1.66
(-3.97%)
USD |
NASDAQ |
Aug 28, 16:00
40.11
0.00 (0.00%)
Pre-Market: 20:00
IDEAYA Biosciences 1 Year Total Returns (Daily) : 60.89% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 60.89% |
| August 27, 2026 | 67.08% |
| August 26, 2026 | 67.26% |
| August 25, 2026 | 71.91% |
| August 24, 2026 | 59.39% |
| August 21, 2026 | 61.06% |
| August 20, 2026 | 60.81% |
| August 19, 2026 | 61.62% |
| August 18, 2026 | 53.25% |
| August 17, 2026 | 50.18% |
| August 14, 2026 | 48.95% |
| August 13, 2026 | 50.20% |
| August 12, 2026 | 56.68% |
| August 11, 2026 | 61.30% |
| August 10, 2026 | 59.05% |
| August 07, 2026 | 65.19% |
| August 06, 2026 | 53.36% |
| August 05, 2026 | 49.42% |
| August 04, 2026 | 44.44% |
| August 03, 2026 | 45.86% |
| July 31, 2026 | 45.79% |
| July 30, 2026 | 43.59% |
| July 29, 2026 | 43.28% |
| July 28, 2026 | 44.52% |
| July 27, 2026 | 50.08% |
| Date | Value |
|---|---|
| July 24, 2026 | 42.57% |
| July 23, 2026 | 53.32% |
| July 22, 2026 | 58.95% |
| July 21, 2026 | 65.02% |
| July 20, 2026 | 64.20% |
| July 17, 2026 | 63.01% |
| July 16, 2026 | 62.21% |
| July 15, 2026 | 71.44% |
| July 14, 2026 | 62.31% |
| July 13, 2026 | 60.81% |
| July 10, 2026 | 62.24% |
| July 09, 2026 | 62.30% |
| July 08, 2026 | 76.97% |
| July 07, 2026 | 91.45% |
| July 06, 2026 | 78.14% |
| July 02, 2026 | 71.76% |
| July 01, 2026 | 71.26% |
| June 30, 2026 | 77.31% |
| June 29, 2026 | 71.03% |
| June 26, 2026 | 64.83% |
| June 25, 2026 | 64.88% |
| June 24, 2026 | 66.57% |
| June 23, 2026 | 62.98% |
| June 22, 2026 | 57.96% |
| June 18, 2026 | 42.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Incyte Corp. | 48.59% |
| Xencor, Inc. | 223.7% |
| UroGen Pharma Ltd. | 126.7% |
| MeiraGTx Holdings Plc | 84.51% |
| ACADIA Pharmaceuticals, Inc. | 10.98% |